Latest news – Business Information

In the inflammatory gastroenterology trial in which MediServ participates, most patients are now in the open-label phase. For the Rheumatology study the anticipated number of patients is almost included. In the meantime also patient number 2 and 3 are included in the gastroenterological oncology study.

>> Read more